F.HOFFMANN-LA ROCHE & CIE
| Marque | Composition | Formes | Prix à partir de | CNAM |
|---|---|---|---|---|
| ACTEMRA | Tocilizumab | Sol. Inj. P. Perf., Sol. Inj. Sous Cutanée | non | |
| AVASTIN | Bevacizumab | Sol. Inj. P. Perf. | non | |
| CYMEVENE | Ganciclovir | Pdre. Prép. Inj. | non | |
| GAZYVARO | Obinutuzumab | Sol. Inj. P. Perf. | non | |
| MABTHERA | Rituximab | Sol. Inj. | non | |
| OCREVUS | Ocrelizumab | Sol. Inj. P. Perf. | non | |
| PEGASYS 135mcg | Peginterferon alpha-2a | Sol. Inj | non | |
| PERJETA | Pertuzumab | Sol. Inj. P. Perf. | non |